Event Details
Biotech Outsourcing Strategies (BOS) Basel is a leading partnering event focused on outsourcing strategies for drug development, particularly in small molecules, biologics, peptides, and oligonucleotides. It brings together pharmaceutical and biotech companies with CROs and CDMOs to foster collaboration, share insights, and explore innovations in CMC, regulatory support, and scalable manufacturing.
Neuland is proud to sponsor and participate in Biotech Outsourcing Strategies (BOS) Basel, June 30 – July. Meet our team at booth number 25 to discuss how we specializes in custom development and custom manufacturing of molecules to your exact specifications, ensuring quality, compliance and scalability.
Event Highlight - Day 1 Presentation
Join Dr. Sreekanth Thogiti, Director – Process Chemistry, as he shares insights into advancing molecules from early discovery to GMP-ready manufacturing.
Session Title: Engineering a Convergent, GMP-Ready Route to CR6086Na: Bridging Medicinal Chemistry to Clinical Manufacturing
Date: 30 June 2026
Time: 4:20 PM
This session will explore the development of an efficient, scalable synthesis route, highlighting the critical transition from medicinal chemistry to clinical-stage manufacturing.
Why connect with Us?
End to end CDMO solutions for your molecule’s development
For early-stage development or commercial-scale manufacturing, our team provides comprehensive CDMO services aligned with the molecule’s lifecycle. We are available to discuss specific challenges and outline support options for each phase through tailored solutions
Operational integration to manage timelines
To streamline development and optimize scaling, we can review operational objectives and explain how our integrated facilities can help reduce complexity, maintain quality assurance, and manage risks according to the requirements of the molecule.
Meet the team
Discussions with senior management and scientific staff are available to address strategies suited to the requirements of various molecules. Support is provided for synthesis challenges and preparation for large-scale production.
Schedule a time with our team at BOS Basel to discuss how we may assist with your drug development objectives.
Let’s build the future of pharma—together.
Event Name : BOS Basel 2026
Booth No #25
30 Jun - 01 Jul, 2026
Basel, Switzerland
Meet the leadership team at CPHI NorthAmerica

Saradhi Bolli
Global Business Development Head – CDMO Services

Nicola Guibellina
VP Business Development - CDMO Services

Dr Sreekanth Thogiti
Director - Process Chemistry